Analystreport

VistaGen Therapeutics (NASDAQ:VTGN) had its "outperform" rating reaffirmed by analysts at William Blair.

VistaGen Therapeutics, Inc.  (VTGN) 
Last vistagen therapeutics, inc. earnings: 2/13 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vistagen.com